Why is Astrazeneca Phar falling/rising?

As of 14-Aug, Astrazeneca Pharma India Ltd's stock price is currently at Rs 8,443.90, reflecting a slight increase of 12.9 points or 0.15%. Today's price summary indicates that the stock has gained after two consecutive days of decline, reaching an intraday high of Rs 8,987.4, which represents a 6.6% increase. Despite this, the stock has shown high volatility today with an intraday fluctuation of 5.28%. Over the past week, the stock has decreased by 3.26%, and over the past month, it has fallen by 7.93%. However, it has performed well year-to-date, with a return of 15.12%, and has consistently outperformed the benchmark indices over the past year and three years. The company has demonstrated strong financial performance, with a 39.08% growth in profit after tax over the last six months and a high return on equity of 19.06%.
In the broader market context, Astrazeneca's recent short-term performance has been weaker compared to the Sensex, which has only declined by 0.03% over the past week. However, the stock's year-to-date performance of 15.12% significantly outpaces the Sensex's 3.15% increase, indicating strong investor confidence despite recent volatility. The rising investor participation, evidenced by a 264.67% increase in delivery volume, suggests that there is renewed interest in the stock, which may contribute to its recent price stabilization and slight upward movement. Overall, while the stock has faced short-term challenges, its solid fundamentals and consistent returns over the years provide a positive outlook for investors.